New animal model to study craniofacial pain by manipulating genes

Mar 25, 2010
Pictured is a closeup of trigeminal nerve cells. Credit: Ewa Balkowiec-Iskra, M.D., Ph.D.

Using a novel animal model to study craniofacial pain, researchers at Oregon Health & Science University's School of Dentistry have discovered that when tissues are inflamed, the nerve cells carrying pain information from the head to the brain produce in large quantities a protein involved in pain signaling.

The finding could play a significant role in the development of new treatments for craniofacial conditions, such as migraines, temporomandibular joint (TMJ) disorder, trigeminal neuralgia, and toothache. The findings were published online on March 9, and will appear in one of the upcoming issues of the journal Neuroscience.

According to the National Institutes of Health (NIH), approximately 10 percent of Americans suffer from chronic pain conditions, and inflammatory craniofacial pain is one of the most frequent.

Head pain is signaled to the brain by the trigeminal nerve. The trigeminal nerve sends information about pain associated with migraines, TMJ disorder, trigeminal neuralgia, head and neck cancer, periodontal disease, dental procedures, and other conditions. Yet, the molecular mechanisms of trigeminal pain are not well understood. Studies suggest most craniofacial pain disorders are caused by inflammation.

The OHSU dental school research team previously found that trigeminal nerve cells make a molecule called brain-derived neurotrophic factor (BDNF), which plays a critical role in the development and normal functioning of the nervous system. They also showed that stimulation of trigeminal nerve cells, as experienced during craniofacial pain, leads to the release of BDNF and, in a separate study, noted that BDNF is involved in the mechanisms of migraines. Now, the team has found that tooth pulp inflammation of as few as two molar teeth leads to a dramatic and widespread increase in BDNF production by trigeminal , even those not connected to the teeth.

"Thanks to a tremendous collaborative effort of experts in several different disciplines of dentistry and , we were able to develop an amazing model to study molecular mechanisms of craniofacial pain using genetic manipulations," said Agnieszka Balkowiec, M.D., Ph.D., principal investigator, associate professor of integrative biosciences in the OHSU School of Dentistry, and adjunct assistant professor of physiology and pharmacology in the OHSU School of Medicine. "With this model, we will finally be able to dissect specific mechanisms of BDNF action and its role in inflammatory pain conditions."

Explore further: Does getting 'expensive' drug affect how much patient benefits?

More information: http://dx.doi.org/10.1016/j.neuroscience.2010.03.002

Related Stories

Scientists uncover mechanism for dental pain

Jan 08, 2009

Researchers at Oregon Health & Science University's School of Dentistry have discovered a novel function of the peptide known as Nerve Growth Factor (NGF) in the development of the trigeminal nerve. The trigeminal nerve provides ...

Scientists identify protein that may promote migraines

Mar 08, 2007

A University of Iowa study may provide an explanation for why some people get migraine headaches while others do not. The researchers found that too much of a small protein called RAMP1 appears to "turn up the volume" of ...

Treatment blocks pain without disrupting other functions

Oct 03, 2007

A combination of two drugs can selectively block pain-sensing neurons in rats without impairing movement or other sensations such as touch, according to a new study by National Institutes of Health (NIH)-supported investigators. ...

Whiplash may produce delayed jaw pain

Aug 16, 2007

One in three people exposed to whiplash trauma is at risk of developing delayed TMJ symptoms that may require treatment, according to research published in the August issue of The Journal of the American Dental Association.

Recommended for you

Why upper motor neurons degenerate in ALS

10 hours ago

For the first time, scientists have revealed a mechanism underlying the cellular degeneration of upper motor neurons, a small group of neurons in the brain recently shown to play a major role in ALS pathology.

Study finds novel compound switches off epilepsy development

11 hours ago

Researchers at the LSU Health New Orleans Neuroscience Center of Excellence have found that a novel compound they discovered helps curtail the onset and progression of temporal lobe epilepsy. The finding, which may contribute ...

A challenge to expedite Genervon's new ASL drug

Jan 27, 2015

(Medical Xpress)—The Ice Bucket Challenge to raise awareness for Amyotrophic lateral sclerosis (ALS) went viral on social media last summer. Over 1.2 million videos were posted on Facebook alone. The difficulty ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.